Emergent Biosolutions
EBS
EBS
238 hedge funds and large institutions have $1.88B invested in Emergent Biosolutions in 2017 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 104 increasing their positions, 60 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.58% more ownership
Funds ownership: 90% → 97.58% (+7.6%)
47% less call options, than puts
Call options by funds: $684K | Put options by funds: $1.29M
Holders
238
Holding in Top 10
3
Calls
$684K
Puts
$1.29M
Top Buyers
| 1 | +$26.8M | |
| 2 | +$20.1M | |
| 3 | +$16.4M | |
| 4 |
O
OppenheimerFunds
New York
|
+$15M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$12.2M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$12.4M | |
| 3 | -$6.66M | |
| 4 |
GAM
Gotham Asset Management
New York
|
-$5.45M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$5.36M |